JPWO2020264201A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020264201A5
JPWO2020264201A5 JP2021577157A JP2021577157A JPWO2020264201A5 JP WO2020264201 A5 JPWO2020264201 A5 JP WO2020264201A5 JP 2021577157 A JP2021577157 A JP 2021577157A JP 2021577157 A JP2021577157 A JP 2021577157A JP WO2020264201 A5 JPWO2020264201 A5 JP WO2020264201A5
Authority
JP
Japan
Prior art keywords
dosage form
oral dosage
lemborexant
acceptable salt
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538170A (ja
Publication date
Priority claimed from PCT/US2019/067955 external-priority patent/WO2020263331A1/en
Application filed filed Critical
Priority claimed from PCT/US2020/039674 external-priority patent/WO2020264201A1/en
Publication of JP2022538170A publication Critical patent/JP2022538170A/ja
Publication of JPWO2020264201A5 publication Critical patent/JPWO2020264201A5/ja
Pending legal-status Critical Current

Links

JP2021577157A 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント Pending JP2022538170A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2019003933 2019-06-26
USPCT/US2019/003933 2019-06-26
USPCT/US2019/067955 2019-12-20
PCT/US2019/067955 WO2020263331A1 (en) 2019-06-26 2019-12-20 Lemborexant for treating sleep issues
PCT/US2020/039674 WO2020264201A1 (en) 2019-06-26 2020-06-25 Lemborexant for treating sleep issues

Publications (2)

Publication Number Publication Date
JP2022538170A JP2022538170A (ja) 2022-08-31
JPWO2020264201A5 true JPWO2020264201A5 (es) 2023-06-21

Family

ID=83059912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577157A Pending JP2022538170A (ja) 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント

Country Status (1)

Country Link
JP (1) JP2022538170A (es)

Similar Documents

Publication Publication Date Title
ES2317196T3 (es) Metodo para tratar y diagnosticar la respiracion irregular durante el sueño usando zonisamida y medio para llevar a cabo el metodo.
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2505944B2 (ja) （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2009543761A (ja) レボドパ／カルビドパの長期間２４時間腸内投与
RU2008150622A (ru) Лечение агонистом мелатонина
RU2008119454A (ru) Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
TW202339764A (zh) 19去甲c3,3-二取代之c21-n-吡唑類固醇及其使用方法
JP4996803B2 (ja) 抗高血圧剤に対する抵抗性及び関連状態を処置する方法及び処方物
AU2014249530A1 (en) Use of levocetirizine and montelukast in the treatment of anaphylaxis
JP2003523384A (ja) 睡眠時呼吸障害を治療及び診断する方法並びにその方法を実施する手段
JP2016505050A5 (es)
WO2008111384A1 (ja) 上皮改善剤
WO2016120787A1 (en) Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms
JP2004091473A (ja) 色素沈着改善治療薬
JP6514420B2 (ja) 睡眠時無呼吸の処置のためのスルチアム
Ferini-Strambi et al. Treatment of restless legs syndrome
JPWO2020264201A5 (es)
JP2019535830A5 (es)
EP3362047A2 (en) Low dose oral dipyridamole compositions and uses thereof
RU2022101535A (ru) Лемборексант для лечения проблем со сном
RU2006110550A (ru) Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна
JP2002523362A5 (es)
RU2002115814A (ru) Лечение системной красной волчанки с помощью дегидроэпиандростерона
Rosalyn et al. The Management of Oral Pemphigus Vulgaris in a Hypertensive Patient: A Case Report